← Leaderboards
Alex Handler Wagner
Washington University
$3,743,658
Attributed
$4,283,062
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2017–25$2M$1.5M$1M$500K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,283,062 · 5
By mechanism
R35$2,398,558 · 1
U24$809,106 · 1
R00$727,179 · 1
K99$226,019 · 1
F32$122,200 · 1
Top collaborators
- Malachi Griffith1 shared
- Obi L. Griffith1 shared
Most similar at Washington University
Same institution · by research overlap
- Obi L. Griffith$8,133,812
- Daniel Scott Marcus$32,798,713
- Aristeidis Sotiras$2,788,208
- Erika A Waters$6,585,228
- Dennis L Barbour$2,296,042
Others in their field
Other Emerging Leaders on “Malignant Neoplasms”
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
- Leonard Freedmand · Leidos Biomedical Research, Inc.$108,968,336
- Beverly Hayes · Leidos Biomedical Research, Inc.$98,336,166
- Martha Hering · Westat, Inc.$57,098,843
Research focus
Malignant NeoplasmsVariantResourcesGenomicsLiteratureReportingGenomeCollectionGenomic MedicineGenetic VariantDesignCostServicesGenomic VariationDiagnosisSourceLinkDatabasesKnowledgebaseTumorCohort StudiesCohortClinical PracticeClinically Significant
Grant awards (15)
Accelerating the expert-crowdsourcing of cancer variant interpretation in CIViC$809,106
U24 · FY2025 · CA
Development and validation of a computable knowledge framework for genomic medicine$411,289
R35 · FY2025 · HG · contact PI
Development and validation of a computable knowledge framework for genomic medicine$414,446
R35 · FY2024 · HG · contact PI
Development and validation of a computable knowledge framework for genomic medicine$414,446
R35 · FY2023 · HG · contact PI
Tools for Normalizing and Interpreting the Clinical Actionability of Genomic Variants$235,720
R00 · FY2023 · HG · contact PI
Development and validation of a computable knowledge framework for genomic medicine$414,446
R35 · FY2022 · HG · contact PI
Development and validation of a computable knowledge framework for genomic medicine$323,325
R35 · FY2022 · HG · contact PI
Tools for Normalizing and Interpreting the Clinical Actionability of Genomic Variants$242,459
R00 · FY2022 · HG · contact PI
Development and validation of a computable knowledge framework for genomic medicine$420,606
R35 · FY2021 · HG · contact PI
Tools for Normalizing and Interpreting the Clinical Actionability of Genomic Variants$249,000
R00 · FY2021 · HG · contact PI
Tools for Normalizing and Interpreting the Clinical Actionability of Genomic Variants$92,118
K99 · FY2020 · HG · contact PI
TOOLS FOR NORMALIZING AND INTERPRETING THE CLINICAL ACTIONABILITY OF GENOMIC VARIANTS$18,900
K99 · FY2020 · HG · contact PI
TOOLS FOR NORMALIZING AND INTERPRETING THE CLINICAL ACTIONABILITY OF GENOMIC VARIANTS$115,001
K99 · FY2019 · HG · contact PI
A Collaborative Reporting Tool For Interpreting Genomic Events In Lung Cancers$63,034
F32 · FY2018 · CA · contact PI
A Collaborative Reporting Tool For Interpreting Genomic Events In Lung Cancers$59,166
F32 · FY2017 · CA · contact PI